Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 22,600
+300 (1.35%)
Oct 31, 2025, 1:39 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 223.14 billion as of October 30, 2025. Its market cap has increased by 59.45% in one year.
Market Cap
223.14B
Enterprise Value
179.29B
Revenue
7.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
22,600.00
Market Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has decreased from 291.82B to 223.14B, a decrease of -23.54%. That is a compound annual growth rate of -2.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 223.14B | 21.38% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | 566.53B | 52.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.90T |
| ALTEOGEN | 24.95T |
| SK Biopharmaceuticals | 8.88T |
| Yuhan | 8.77T |
| HLB Co., Ltd. | 6.30T |
| Peptron | 6.13T |
| PharmaResearch | 5.36T |